SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

12 Aug 2025 Evaluate
The revenue slipped marginally during the June 2025 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2025 is Rs. -118.05 millions as compared to Net Profit of Rs. 2.48 millions of corresponding quarter ended June 2024Operating profit Margin for the quarter ended June 2025 slipped to -118.04% as compared to 2.49% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.21 3.02 -93.05 0.21 3.02 -93.05 6.20 18.38 -66.27
PBIDT -118.04 2.49 -4840.56 -118.04 2.49 -4840.56 5.03 16.52 -69.55
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
PBDT -118.05 2.49 -4840.96 -118.05 2.49 -4840.96 5.03 16.52 -69.55
Depreciation 0.00 0.01 0.00 0.00 0.01 0.00 0.05 0.08 -37.50
PBT -118.05 2.48 -4860.08 -118.05 2.48 -4860.08 4.98 16.44 -69.71
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.55 4.43 -65.01
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.44 1.69 -126.04
PAT -118.05 2.48 -4860.08 -118.05 2.48 -4860.08 3.43 12.01 -71.44
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Starsource Multitrad Share Price

123.90 5.85 (4.96%)
16-Apr-2026 12:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.60
Dr. Reddys Lab 1223.40
Cipla 1232.00
Zydus Lifesciences 936.35
Lupin 2304.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×